Wednesday, November 29, 2017

To create the best in the history of a vaccine against malaria

American scientists reported a major breakthrough in the prevention of malaria in recent history. To create a vaccine that provides maximum protection of the human from this dangerous disease.

 To create the best in the history of a vaccine against malaria  a vaccine against malaria

In Russia and other developed countries, malaria is considered something exotic, but in the poorest countries of the Third World is the main cause of mortality. Malaria is dying more people than heart disease, cancer or other ailments. And this disease is not age, it is with the same force and kills the young and the elderly. That is why the science of this energy is working on a vaccine against malaria, the world's richest man Bill Gates has donated to the research more than a billion dollars.

 To create the best in the history of a vaccine against malaria  a vaccine against malaria

Apparently, the money is still given result. US scientists have created vaccine against malaria   called PfSPZ. In clinical trials, 100% of people who received a higher dose of medication, do not get sick with malaria. Just experiments attended by 57 volunteers, 40 of whom received injections in different doses.

A vaccine against malaria   PfSPZ made on the basis of the malaria parasite Plasmodium falciparum, is in the infectious stage, that is contagious. To study these parasites have been weakened by radiation, and then frozen. However, they kept their whole form and can infect humans. The volunteers were bitten by parasites, and within a week they were to show signs of the disease.

Get full intravenous PfSPZ volunteers were completely protected - no one has developed malaria. Those who got the lower dose of 9 people were infected with 3 out of 12 do not immunized malaria occurred in 11. All patients received timely treatment of malaria and recovered. About any side effects of the vaccine is not known. (READ MORE)



Industry News

Go back to the main page

No comments:

Post a Comment